ARHI is characterised by a non-syndromic bilateral, sensorineural hearing loss that progresses with increasing age and is an established risk factor for depression [6] [7] [8] and dementia [9] [10] [11] [12] . Hearing loss was ranked fourth in the latest study into the Global Burden of Diseases
Age-related hearing impairment (ARHI) is the most common sensory impairment in the aging
population; a third of individuals are affected by disabling hearing loss by the age of 65
1 . ARHI is a multifactorial condition caused by both genetic and environmental factors, with estimates of heritability between 35% and 55% [2] [3] [4] . The genetic risk factors and underlying biological pathology of ARHI are largely unknown, meaning that targets for new therapies remain elusive.
We performed genome-wide association studies (GWAS) for two self-reported hearing phenotypes, hearing difficulty (HDiff) and hearing aid use (HAid), using over 250,000 UK ARHI is characterised by a non-syndromic bilateral, sensorineural hearing loss that progresses with increasing age and is an established risk factor for depression [6] [7] [8] and dementia [9] [10] [11] [12] . Hearing loss was ranked fourth in the latest study into the Global Burden of Diseases 13 , yet hearing amplification devices are the only treatment option currently available for ARHI. ARHI is expected to be a highly genetically heterogeneous trait given that over 150 genetic loci have been identified in non-syndromic hereditary hearing loss alone (https://hereditaryhearingloss.org/). Previous GWAS of ARHI have identified a small number of promising candidate genes, though there has been poor replication of findings to date, possibly reflecting varied phenotyping approaches and limited sample sizes [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] .
We conducted two GWAS using the self-reported hearing difficulty and hearing aid use of UK Biobank (UKBB) participants and refined our results using a combination of conditional analysis, replication analysis, in silico annotation and in vivo expression analysis (see Figure 1 for study design). Our aim was to identify the genetic components of adult hearing impairment in the UK population and provide insight into the pathology of ARHI.
UKBB participants were categorised using a case-control design based on responses to questions regarding hearing difficulty (HDiff, n=498,281) and hearing aid use (HAid, n=316,629) (Supplementary Figure 1) . A linear mixed-effects model was used to test for association between 9,740,198 SNPs and the two traits, using BOLT-LMM v.2 25 , which corrects for population stratification and within sample relatedness. Following additional quality control filters and selection of white British participants (described in online methods), the final samples for association analyses were n=250,389 for HDiff and n=253,918 for HAid (Supplementary Figure 1) .
The studies identified 2,080 and 240 SNPs at genome-wide significance (P<5E-08) for HDiff and HAid The Variant Effect Predictor (VEP) 27 was used to map independent lead SNPs to the nearest protein coding genes, using the GRCh37 genomic reference. Of 41 independent SNPs associated with HDiff, six variants lie in exons, four of which result in missense mutations in EYA4, CDH23, KLHDC7B and TRIOBP, 21 SNPs lie within introns and 14 are intergenic (Table 1) . Six of the independent SNPs associated with HAid reside in intronic regions and 1 is intergenic. Significant gene loci common to both traits were NID2, ARHGEF28, CTBP2 and EYA4 (Supplementary Figure 3) . Variants within EYA4
have been reported in autosomal dominant non-syndromic hearing loss [28] [29] [30] , while NID2 and ARHGEF28 are new associations with hearing impairment. CTBP2, though not previously linked to genetic risk of ARHI, encodes a protein component of the inner ear hair cell pre-synaptic ribbon 31 .
Replication was attempted for the lead SNPs (41 HDiff and 7 HAid) by meta-analysing three independent samples; the remaining Caucasians in the UKBB cohort (white, non-British Europeans), Tables 1 and 2) .
We investigated whether any of the candidate genes identified in adult hearing in previously published genetic association studies were replicated within the discovery White British sample (Table 2 ) and found two previous variant associations located in close proximity to ISG20 and within TRIOBP, which were identified in a GWAS performed with data from electronic health records 24 .
While ISG20 is a novel association, mutations in TRIOBP cause one form of autosomal recessive nonsyndromic deafness, DFNB28 32, 33 . No other lead variants from previous ARHI genetic studies were replicated at nominal level in our analysis, including the first reported ARHI associated gene variant in
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Functional gene annotation was undertaken with genes mapped from SNPs associated at a suggestive level in the HDiff association analysis. Genes were significantly enriched in a number of processes required for auditory function: synaptic activities, trans-synaptic signalling, nervous system processes, modulation of chemical synaptic transmission, positive dendritic spine morphogenesis, and inner ear morphology as well as cognition, learning or memory. These genes were also significantly enriched with mouse phenotype ontologies, mostly relating to inner ear abnormalities and abnormal auditory brainstem response, and were significant at FDR 0.05 ( Figure 3 ). As well as suggesting pathogenic pathways, this finding demonstrates the shared genetic pathology in mouse and human auditory systems, supporting the use of mouse models to study human auditory function.
In silico tissue-specific gene expression analysis undertaken with MAGMA 34 indicates a significant association between HDiff suggestive genes and transcription levels of genes in brain (P = 5.4E-04;
Supplementary Figure 4 Figure 5 ). Previous reports demonstrate a role for ARHGEF28 in regulation of neurofilaments 38, 39 and axon growth and branching 40 . It has also been implicated in the pathogenesis of motor neuron disease through formation of neurofilament and ARHGEF28 aggregates 41 .
Our study should be received in the context of its limitations; first, there is currently a lack of adequately powered studies with which to replicate our results. Despite meta-analysing three cohorts, the replication sample remains an order of magnitude smaller than the discovery set. However, the identification of known hearing genes, gene annotation analysis and the results of in vivo expression provide support and putative mechanisms for involvement of these genes in hearing loss.
Second, we cannot confirm age at hearing difficulty onset or hearing aid prescription, making an accurate diagnosis of ARHI a challenge. Some of the associations, for example, may be driven by the presence of individuals with congenital hearing impairment due to highly penetrant variants. We reduced the likelihood of this by implementing a minor allele frequency (MAF) cut-off of 0.01 (i.e.,
higher than the rate of variants in congenital deafness) and by excluding participants who selected 'I am completely deaf' in the UKBB questionnaire.
In summary, we have conducted the largest GWAS to date on adult hearing and have identified 44 associated independent loci. Although several genes identified are known to have a role in congenital deafness or have been identified in mouse models, 33 of the 44 loci identified have not previously been associated with hearing loss phenotypes in humans or mice. For three such genes we demonstrated localised cell specific expression within the mouse adult cochlea. This study demonstrates that selfreported hearing loss in adults is suitable for use in association studies using large cohorts such as the UKBB. Our results present a framework for further study into the auditory pathways influenced by the genomic loci identified.
Online methods
Participants
The cohort used for discovery association analysis consisted of UK Biobank (UKBB) participants with 'White British' ancestry. The UKBB sample classification 'White British' is derived from both Principal Component (PC) analysis and self-declared ethnicity 42 . Samples with excess heterozygosity, excess relatedness and sex discrepancies were identified and removed prior to analysis, resulting in samples sizes of n =250,389 and n = 253,918 for hearing difficulty (HDiff) and hearing aid (HAid) use respectively.
For replication analysis, we used the UKBB ethnic group 'Caucasians' (white non-British Europeans).
To assign participants into discrete ancestry clusters, we used the 1st and 2nd PC vectors provided by UKBB. A k-means clustering algorithm was applied to generate clusters for each PC. We then combined cluster indices for the PCs (1.1, 1.2, …, 5.5), compared them against self-reported ancestry and assigned the ancestry group accordingly. If contradictory, the pairwise clusters took precedence over the selfreport grouping.
The two other samples used for replication analysis were the English Longitudinal Study of Aging (ELSA) and TwinsUK. These datasets were selected as they consist of predominantly Caucasian samples and include relevant questionnaire data. ELSA is a longitudinal study, consisting of around 12,000 respondents from the Health Survey for England. Eight waves of data collection have been completed since 2002 43 . TwinsUK is the largest adult twin registry in the UK and comprises over 13,000
healthy twin volunteers aged 16-98. Collection of data and biologic materials commenced in 1992 and is ongoing. During study participation, twins complete health and lifestyle questionnaires and attend clinical evaluations 44 .
Phenotype definitions
Two phenotypes were derived for this study; a phenotype representing self-reported hearing difficulty (HDiff) and a phenotype representing self-reported hearing aid use (HAid). Participants in the UKBB study completed a touchscreen questionnaire during their visit to the assessment centre, which included questions regarding hearing status. Participants were assigned case/control status based on their responses to questionnaire measures regarding hearing difficulty and hearing aid use. Details of how the UKBB phenotype was derived are displayed in Supplementary Figure 1 . If participants answered the questionnaire twice, i.e. attended an assessment centre for the repeat visit, the answer at the second time point was used in analysis, in order to increase the mean age of the sample. To reduce the likelihood of including congenital forms of deafness, participants who selected 'I am completely deaf' in the UKBB questionnaire were excluded from analysis.
Note that a further, objective measure of hearing, the speech reception threshold using the 'Digits in Noise' (DIN) protocol, was obtained from 160,955 of the UK Biobank participants 45, 46 Preliminary heritability assessment of the DIN did not yield clear heritability or association with age and therefore it was not considered suitable for the present study.
Questionnaire responses for the ELSA and TwinsUK replication samples were derived to obtain comparable phenotypes to the UKBB phenotype (Supplementary Figure 1) . For the ELSA sample, case/control phenotypes were derived from responses to questionnaire measures collected during study Wave 7. The HDiff phenotype was derived using responses from two questions; "Do you ever have any difficulties with your hearing?" and "Do you find it difficult to follow a conversation if there is background noise, such as TV, radio or children playing (using a hearing aid as usual)?" Cases consist of participants who responded "Yes" to both questions, and controls who responded "No" to both questions. As in the UKBB analysis, controls who report hearing aid use or age <50 were removed, as 
Genotyping and imputation
The ~500,000 samples in UKBB were genotyped on one of two arrays; 50,000 samples were genotyped on the Affymetrix UK BiLEVE Axiom array while the remaining ~450,000 were genotyped on the Affymetrix UK Biobank Axiom® array. The two arrays shared 95% coverage resulting in >800,000
genotyped SNPs. Imputation was carried out centrally by UKBB, primarily using the HRC reference panel and IMPUTE2 47 . SNPs which do not feature on this panel were imputed with the UK 10K and 1000G panel. Analysis in this study was conducted with version 3 of the UKBB imputed data with 487,409 samples imputed and available for analysis following UKBB centrally performed QC filters.
ELSA samples were genotyped at UCL Genomics in two batches using the Illumina HumanOmni 2.5M
platform. Imputation was carried out centrally by ELSA with IMPUTE2, using the 1000 Genomes phase I data set 48 (https://www.elsa-project.ac.uk/uploads/elsa/elsa_analysis.pdf).
Genotyping of TwinsUK was conducted with a combination of Illumina arrays; HumanHap300, HumanHap610Q, 1M-Duo and 1.2MDuo 1M. The imputation reference was 1000G Phase3 v5 (GRCh37).
Statistical analysis
Discovery association was performed using a linear mixed-effects model approach to test for association between imputed SNP dosages and the two traits. BOLT-LMM v.2 25 was used for the association analysis, which corrects for population stratification and within-sample relatedness. In addition, the analysis was adjusted for age, sex, UKBB genotyping platform and UKBB PCs1-10. For quality control, SNPs were filtered based on two thresholds: (1) minor allele frequency (MAF) > 0.01; and (2) INFO score > 0.7. By implementing an MAF cutoff of 0.01, we reduced the likelihood of including participants with forms of congenital deafness, as we only detected variants that occur at least in 1/100 participants, a higher rate of variants than the rate of congenital deafness. Individuals with < 98% genotype call rate were removed. Conditional and joint SNP analysis was performed to identify independent signals within highly associated regions, using GCTA-COJO 26 . This analysis requires the linkage disequilibrium reference sample, which was obtained by random selection of 10,000 individuals from the UKBB cohort with White British ancestry. The reference sample size was selected to maximise power based on previous data simulations 49 . Independent SNPs identified with GCTA-COJO were mapped to the nearest protein coding gene using variant effect predictor (VEP), genome build GRCh37.
VEP was used to establish whether the SNP was in an exonic, intronic or intergenic region, and also the functional consequence of the variant at that position. Univariate linkage disequilibrium (LD) score regression was used to calculate whether inflated test statistics were likely due to the polygenic nature of the trait or confounding bias, by analysing the relationship between test statistic and LD SNPs identified with conditional analysis (Table 1) were tested for association with HDiff and HAid phenotypes in each of the three cohorts UKBB (non-white British), TwinsUK and ELSA. The UKBB white non-British sample was examined using the same protocol as the White British dataset described above, under the linear mixed models method with BOLT-LMM adjusting for age, sex, UKBB PCs 1-10 and genotyping platform. The TwinsUK sample was analysed using a linear mixed-effects model regression adjusting for age and sex with GEMMA 51 , accoutning for family structure. The ELSA samples for HDiff and HAid are <5,000 and one of each pair of related individuals was excluded from analysis (relatedness was estimated in PLINK 1. 9 52 ), therefore PLINK2 logistic regression was used to test for association in the ELSA sample, adjusting for age and sex.
For SNPs significantly associated with ARHI in the discovery, a fixed-effect inverse-variance weighted meta-analysis was conducted using METAL 53 version 2011-03-25 with the three samples: white non-British UKBB, ELSA and TwinsUK. BOLT-LMM does not report analysed sample size per SNP, so to obtain the weight of the UKBB replication sample per SNP, sample size was calculated from PLINK linear regression analysis.
Gene prioritization, pathway and tissue enrichment analysis
Summary statistics from the UKBB HDiff trait were input for Functional Mapping and Annotation of Genome-wide Association Studies (FUMA) 54 as an alternative way to identify independent significant SNPs, lead SNPs, and functional annotations. Firstly, SNP2GENE function within FUMA was used to identify (i) independent significant SNPs (P≤5E-08) that were independent from each other at r 2 <0.6, and (ii) lead SNPs -significant SNPs that were independent from each other at r 2 <0.1. In addition, genomic risk loci borders were determined using candidate/tagged SNPs, which were SNPs in LD with independent significant SNPs at P ≤ 5E-08 and r 2 ≥ 0.6. Secondly, lead SNPs were mapped to the nearest protein coding genes with a maximum distance of 10kb using VEP 27 . Gene set enrichment analysis was performed using ToppGene Suite 55 . These two steps were repeated with a genome-wide suggestive level (P ≤ 1E-05) to highlight regions that were significant and suggestive of harbouring causal variants.
Alongside SNP-based analysis, we analysed the hearing difficulty GWAS using MAGMA 34 , a genebased method which has been made available within FUMA. In MAGMA, the effect of multiple SNPs is combined together by mapping SNPs to 19,146 protein coding genes based on genomic location of 10kb to the genes, and a P-value describing the association found with hearing difficulty was derived.
Protein localisation in mouse tissue sections
Adult mouse cochleae were collected at p28-p30 from C57BL/6 mice, bred in an in-house facility. Mice were euthanised according to Schedule 1 procedures as described in United Kingdom legislation 
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Availability of data
Data that support the findings of this study are publically available upon successful application from the UK Biobank, the English Longitudinal Study of Aging and TwinsUK.
Derived data from the UK Biobank data fields and GWAS summary statistics that support the findings of this study, will be made available as part of the UK Biobank Returns Catalogue following the publication of this manuscript. Table 2 . Study, publication of previous finding; Gene, gene highlighted in the referenced publication as the lead SNP is either located in the gene region or in close proximity; SNP, single nucleotide polymorphism; CHR, Chromosome; BP, base position; A1, effect allele in analysis; A0, reference allele; INFO, quality metric, combination of imputation score and dosage confidence; UKBB phenotype, phenotype used in this study; A1FREQ, frequency of effect allele in analysis sample; BETA, effect size from BOLT-LMM approximation to infinitesimal mixed model; SE, standard error of the effect size; p-value, infinitesimal mixed model association test p-value. This study did not analyse SNP rs58389158, but analysed rs5756795 which is in complete LD with this SNP in the British population, and referenced in the previous study. This is denoted by * in the table. ARHGEF28 (a,b) , NID2 (c), and CLRN2 (d). Purple indicates lead independent SNP generated from GCTA-COJO conditional analysis. Colouring of remaining SNPs is based on linkage disequilibrium (LD) with the lead SNP. The genes within the region are annotated, and the direction of the transcripts is shown by arrows. Two independent regions were identified within the ARHGEF28 locus; both are shown.
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(e,f,g,h) Immunofluorescence images of adult mouse cochlea, spiral ganglion neurons (e) and organ of Corti (f-h). Vibratome sections stained with the three proteins of interest in mouse inner ear; DAPI (blue) and Phalloidin (magenta) were also used for staining of actin and nuclei respectively. (e) Anti-ARHGEF28 staining is observed in the neuronal cell bodies and axons. (f) Anti-ARHGEF28 (green) is mainly observed in outer and inner hair cells. (g) Anti-NID2 (green) staining is observed lining blood vessels and the epithelial lining of the inner spiral sulcus. (h) Anti-CLRN2 (green) staining is observed in outer and inner hair cells, in addition to the stria vascularis. The scale bar in image (e) represents 100µm. The scale is consistent for all images in this figure.
